Tonic Health MILITARY

Scope and target identity

The target is the UK vitamin and supplement brand Tonic Health operated by Tonic Nutrition Ltd (company 12174856). Companies House records Tonic Nutrition Ltd as an active private limited company, incorporated on 27 August 2019 [pre-2020], with current SIC activities in pharmaceutical-product manufacture and other human-health activities.¹ Companies House lists Sunna van Kampen and Bradley James Waldron as active directors; Sunna van Kampen is the sole active person with significant control disclosed there, holding more than 50% but less than 75% of shares and voting rights.^{2, 3} Tonic’s own site identifies Sunna van Kampen as founder and presents the business as a consumer health/supplement brand.^{4, 5}

Current Tonic pages market consumer products including multivitamin gummies, children’s supplements, effervescent energy/hydration and immunity drinks, magnesium/rest products, and creatine products.^{4, 6, 7, 8, 9, 10} A retrievable mirror of UK trademark registration data records Tonic Nutrition Ltd’s TONIC mark for vitamins, dietary supplements, nutritional supplements and related food products.¹¹ Independent trade coverage in 2025 describes Tonic Health as a UK supplement/wellness brand led by founder and CEO Sunna van Kampen.^{12, 13}

A Boots-hosted Tonic Kids Multi package artwork states “Made in Israel for Tonic Nutrition Ltd.”¹⁴ This establishes a civilian product-manufacturing/origin link to Israel only. The label does not identify an Israeli defence/security end-user, military contract, defence programme, settlement location, or military use.¹⁴

One GOV.UK Armed Forces Covenant page titled “Tonic Health” was not attributed to this target. The page describes its signatory as an East Midlands, 10–49-person, not-for-profit organisation and does not identify Tonic Nutrition Ltd or company 12174856; that metadata does not match the Companies House profile of the West Sussex private limited target.^{15, 1} Search results for unrelated healthcare-software and media businesses using the same or similar name were likewise excluded from the target scope.^{1, 4}

For target-specific screening, the current 2025 OHCHR settlement-business database (A/HRC/60/19), the historical 2023 OHCHR update, UN A/HRC/59/23, PAX’s June 2024 arms-supply report, Al-Haq’s July 2024 business-and-human-rights booklet, and the 2024 Don’t Buy Into Occupation report were inspected. No “Tonic” target match was identified in those checked sources.^{16, 17, 18, 19, 20, 21}

Direct Defence Contracting & Procurement

Ministry of Defence and IDF contracts

No public evidence identified. The live searches and authoritative-source screening conducted for this audit did not identify a contract, tender award, framework agreement or memorandum between Tonic Health/Tonic Nutrition Ltd and the Israeli Ministry of Defence, Israel Defense Forces, Israel Prison Service, Israel Border Police or another Israeli state-security body.^{16, 17, 18, 19} The target’s verified public product and trade-mark materials instead describe consumer vitamins, supplements and wellness products.^{4, 6, 11}

Defence trade-directory listings

No public evidence identified. No target-specific SIBAT, Israeli defence-export-directory, defence exhibition, or defence-procurement listing was identified in the research conducted for this audit.^{18, 19} The PAX report’s named arms suppliers do not include Tonic Health or Tonic Nutrition Ltd.¹⁹

Press releases and official announcements

No public evidence identified. No target corporate announcement or government release describing defence cooperation, a defence joint venture, or a military partnership with an Israeli defence entity was identified.^{4, 5, 18, 19}

Controlling principals

Companies House identifies Sunna van Kampen and Bradley James Waldron as current directors and Sunna van Kampen as the disclosed controlling shareholder/PSC.^{2, 3} no public evidence identified in the targeted searches of these principals for Israeli defence-industry directorships, IDF/IMOD roles, FIDF or reservist-fund donations, equity in Israeli defence primes, or other qualifying military-channel acts.^{2, 3, 18, 19}

Dual-Use Products & Tactical Variants

Militarised product lines

The current target catalogue is made up of consumer nutrition products rather than tactical, ruggedised, mil-spec or defence-grade products.^{4, 6, 7, 8, 9, 10} UK trademark registration data mirrored by Trademarkia similarly places Tonic Nutrition Ltd’s registered goods in vitamins, dietary/nutritional supplements and food categories.¹¹ no public evidence identified of a purpose-built tactical or military variant sold to Israeli security forces.^{6, 11, 18}

Civilian-to-military distinction

The Israeli nexus found in this audit is limited to civilian supplement manufacturing/origin: the Boots-hosted Tonic Kids Multi package artwork states “Made in Israel for Tonic Nutrition Ltd.”¹⁴ The label does not name a military customer or state-security end-user and therefore does not establish military supply.¹⁴

End-user certification and export licensing

No public evidence identified of an export-licence application, end-user certificate or export-control review naming Tonic Health/Tonic Nutrition Ltd in connection with an Israeli military or security end-user.^{18, 19} The available target material describes ordinary consumer supplement distribution.^{4, 6, 11}

Heavy Machinery, Construction & Infrastructure

Equipment in occupied territories

No public evidence identified. Tonic Health’s verified product portfolio is consumer nutrition and supplementation; no target machinery, vehicles or construction equipment were identified.^{4, 6, 11} The OHCHR settlement-business database and DBIO report checked for this audit do not identify the target.^{17, 21}

Direct versus indirect supply

No public evidence identified of Tonic equipment reaching Israeli settlements, military installations or demolition/construction activity through direct sale, an authorised dealer, a distributor or secondary-market resale.^{17, 21} The documented Israeli product-origin evidence concerns consumer gummies and does not establish any heavy-equipment or military end-use channel.^{14, 16}

Construction and engineering contracts

No public evidence identified of target contracts for checkpoints, detention facilities, military bases, the separation barrier, settlement infrastructure or associated maintenance/engineering services.^{17, 18, 21}

Supply Chain Integration with Defence Primes

Component supply

No public evidence identified that Tonic Health/Tonic Nutrition Ltd supplies components, sub-systems, raw materials or specialist manufacturing services to Elbit Systems, Israel Aerospace Industries, Rafael Advanced Defense Systems, IMI/Elbit Land or another Israeli defence prime.^{18, 19} Tonic’s public product material and UK trade-mark record describe finished consumer supplements rather than defence components.^{6, 11}

Specific component categories

No public evidence identified of optical, electronic, propulsion, structural, guidance, communications, armour or other defence-component supply by the target.^{18, 19}

Joint development and co-production

No public evidence identified of a target joint-development programme, co-production agreement, defence technology transfer or licensed manufacturing arrangement with an Israeli defence firm.^{18, 19}

Logistical Sustainment & Base Services

Military installation services

No public evidence identified of Tonic Health/Tonic Nutrition Ltd providing catering, transport, fuel, waste management, facilities maintenance, telecommunications or other sustainment services to IDF bases, training facilities, detention centres or security installations.^{18, 19}

Geographic specificity

No public evidence identified of target services to military/security installations in the West Bank, East Jerusalem, Golan Heights, Negev or elsewhere.^{17, 18, 21} The Israel-origin gummy evidence does not identify a factory location beyond Israel and does not establish activity in occupied territory.^{14, 16}

Shipping, freight and port services

No public evidence identified of target shipping, freight-forwarding or port-handling contracts for Israeli military cargo or arms shipments.^{18, 19}

Munitions, Weapons Systems & Strategic Platforms

Lethal systems manufacturing

No public evidence identified of Tonic Health/Tonic Nutrition Ltd acting as a prime contractor or licensed manufacturer of small arms, artillery, armoured vehicles, tactical drones, naval vessels or other lethal platforms.^{18, 19} Its current public catalogue and trade-mark record concern consumer health products.^{6, 11}

Munitions and precursor materials

No public evidence identified of ammunition, explosive ordnance, chemical propellants, warhead components or munitions-precursor supply by the target to Israeli defence end-users.^{18, 19}

Strategic and existential defence systems

No public evidence identified of a target role in Iron Dome, David’s Sling, Arrow, fighter aircraft, main battle tanks, warships, ballistic missiles or comparable strategic military platforms.^{18, 19}

Critical sub-systems

No public evidence identified of target guidance electronics, fire-control systems, radar components, propulsion units, warhead casings, targeting AI or weapons-integration software.^{18, 19}

Export Licensing, Regulatory & Legal History

Defence export-licence decisions

No public evidence identified of a government decision granting, denying, suspending or revoking a defence export licence for Tonic Health/Tonic Nutrition Ltd products to an Israeli military/security end-user.^{18, 19}

Arms embargo and sanctions compliance

No public evidence identified of an arms-embargo, military-export-control or sanctions enforcement action against the target concerning Israel.^{18, 19}

Legal challenges and judicial review

No public evidence identified of court proceedings or judicial review concerning an alleged Tonic defence-supply relationship with Israel.^{18, 19} By contrast, the public regulatory decisions located for the target are Advertising Standards Authority rulings concerning consumer supplement advertising and health/nutrition claims in 2023, 2024 and 2025; those rulings do not describe military supply or defence trade.^{22, 23, 24}

Civil Society Scrutiny & Documented Investigations

NGO, UN and specialist reports

The checked current OHCHR A/HRC/60/19 database, historical OHCHR 2023 update, A/HRC/59/23, PAX June 2024 arms-supply report, Al-Haq July 2024 business-and-human-rights booklet, and DBIO 2024 report do not identify Tonic Health/Tonic Nutrition Ltd in the text inspected for this audit.^{16, 17, 18, 19, 20, 21} no public evidence identified from that source set of a target-specific military, security or dual-use supply-chain relationship with the Israeli state.^{16, 17, 18, 19, 20, 21}

Boycott and divestment campaigns

No public evidence identified of an organised boycott, divestment or institutional exclusion campaign directed specifically at Tonic Health because of defence-sector activity.^{17, 19, 20, 21} The research did identify civilian Israeli manufacture/origin for a Tonic gummy product, but that fact was not treated as evidence of defence activity or a settlement nexus.^{14, 16}

Corporate response and policy statements

No public evidence identified of a Tonic Health policy statement, contract termination or military end-use monitoring commitment issued in response to pressure about an Israeli defence supply chain.^{4, 5, 18, 19} Tonic’s public-facing materials reviewed for this audit focus on consumer nutrition, health education and supplement products.^{4, 5, 6}

Settlement nexus and constructive-notice checks

No public evidence identified of military-adjacent target supply, construction, demolition or logistics activity in West Bank settlements, East Jerusalem or the Golan Heights.^{17, 21} Because no qualifying Military activity was identified, the research did not establish a target-specific military or settlement-linked activity whose continuation could be assessed after the ICJ Advisory Opinion of 19 July 2024 or the ICC arrest warrants issued in November 2024.^{18, 21} The documented Israeli civilian manufacturing/origin link is not, by itself, evidence of a military or occupied-territory nexus.^{14, 16}

Dated ownership and governance supplement

The replacement confirmation filing records 62 registered holdings totalling 290,695 shares: 190,695 A Ordinary and 100,000 B Ordinary. On that dated share count, Sunna van Kampen held 100,000 B shares, a historical share-count ratio of 34.4003%; Tom Singh and Anna Singh together held 25,727 A shares, 8.8502%; Lucy Mercey and Joseph Wray together held 26,002 A shares, 8.9448%; AwesomeAction Limited held 17,292 A shares, 5.9485%; Side By Side Partnership held 8,450 A shares, 2.9068%; and Rubix Venture Partners held 1,625 A shares, 0.5590%. These percentages are calculations against the 290,695-share total in that filing and are not current October 2026 voting, beneficial-ownership or control percentages.²⁵

The dates require separation. The Companies House filing index identifies the confirmation statement as at 26 August 2025 and the replacement filing index date as 6 May 2026; the replacement PDF records receipt on 24 April 2026 and original-document registration on 22 October 2025.^{25, 26} The current Companies House PSC record supplied by the root reports Sunna van Kampen in the greater-than-50%-and-less-than-75% bands for shares and voting rights, while the dated confirmation share register gives 100,000 of 290,695 registered shares, or 34.4003%. The supplied primary evidence does not reconcile those records, and no exact October 2026 ownership or voting percentage is inferred.^{25, 27}

The articles were adopted on 23 June 2025 and filed on 21 July 2025. They treat A and B as separate ordinary-share classes ranking pari passu subject to stated exceptions. Article 7.3 provides one vote per Equity Share on a poll and contains no B-share vote multiplier.^{28, 26} The same articles define BSI Shareholders as Lucy Mercey and Joseph Wray and give them jointly one BSI Director appointment right while the specified holding condition continues; this is a joint right to one appointment, not two individual appointment rights or an individual absolute veto.²⁸

Article 22.4 provides a director-appointment route for an Investor other than BSI holding, together with the permitted associated holdings specified by the articles, at least 5% of issued Equity Shares. The articles expressly provide aggregation treatment for Tom Singh with Anna Singh and for Ranjit Munro with Kuldip Singh Dhillon. On the dated 290,695-share register, Tom and Anna’s 25,727 shares exceed 5%, whereas Ranjit Munro and Kuldip Singh Dhillon’s combined 10,234 shares represent 3.5205%. Continuing holdings, status under the separate Shareholders’ Agreement, delivery of any appointment notice and actual exercise of any right are not established by these filings.^{25, 28}

The articles define Investors and Major Investors by reference to a separate Shareholders’ Agreement, so the articles alone do not establish the complete individual membership of those contractual categories. Their Investor Majority definition concerns more than 50% of shares held by Major Investors rather than more than 50% of the company.²⁸ Board quorum ordinarily includes the Founder Director and BSI Director to the extent appointed, but article 24 contains interested-director and adjourned-meeting exceptions, so the provision does not establish an absolute individual veto. Article 24.6 separately gives the eligible Founder Director a second or casting vote on tied board votes; this is a board right and does not create a B-share super-vote under article 7.3.²⁸

The written resolution circulated on 1 April 2026 authorised the directors to allot up to 6,524 additional A Ordinary shares and disapplied the relevant pre-emption provision for that authorised allotment. The filing was registered on 14 May 2026. The resolution is authority to allot, not evidence that all or any of those 6,524 shares were actually issued, paid for or added to the current capital denominator.²⁹

These ownership and governance records establish dated holdings and conditional governance rights only. They do not themselves establish a qualifying political/welfare, military-output, digital-technology or economic-capital/operations act by any shareholder, investor or related person, and they do not establish that any conditional appointment right was exercised. Absence of such evidence from these particular filings is not evidence that no such act or exercise exists elsewhere.^{25, 28, 29}

Article 10.1 requires written majority class consent for variation or abrogation of special class rights, with combined-class treatment when classes are treated alike and exceptions under articles 10.2, 10.3 and 17.6. Sunna’s sole registered B holding makes this a relevant dated formal-right protection, not a universal transaction veto. The articles define SBS as the SidebySide EIS Venture Fund acting through WCS Nominees Limited, represented by The SidebySide Partnership International Limited; that definition does not alone reconcile all registered-holder labels or establish an observer seat, individual veto or beneficial percentage.^{25, 28}

Newly documented governance actors - bounded Military update

The root-supplied 26 August 2025 snapshot records Lucy Mercey and Joseph Wray at 13,001 A shares each; the articles define them jointly as the “BSI Shareholders” and give that pair a director-appointment right while they hold Equity Shares. That label/right does not prove the shares are beneficially owned by BRENDON STREET INVESTMENTS LIMITED or that the right has been exercised.^{30, 31} Fresh Companies House records show Lucy Penelope Mercey is an active director of BRENDON STREET INVESTMENTS LIMITED (01066133) and JUNO INVESTMENTS LIMITED (07659145), but those roles do not establish a beneficial bridge from her Tonic holding to either company.^{32, 33}

A fresh Companies House lead shows Joseph Peter William Wray as an active director and PSC of BOOT ROOM HOSPITALITY LIMITED (15529393).^{34, 35} No opened public document in this bounded screen tied that full identity to the Joseph Wray in Tonic’s shareholder snapshot, so the records are not merged.^{30, 34, 35}

The same snapshot records Tom Singh at 12,577 A shares and Anna Singh at 13,150 A shares; article 22.4 aggregates their holdings for the conditional ≥5% appointment test.^{30, 31} Rianta says it is investment adviser to Tom and his family and identifies Anna Singh as founder of Chinti & Parker.³⁶ Companies House identifies RIANTA CAPITAL LIMITED as active overseas company FC027615 with open UK establishment BR009421 for investment advisory services; its current listed directors are Alastair James Alderton, Sarah Jane Cook and Louise Anne Griffin.^{37, 38} Companies House records Anna Mundeep Singh as an active director of CHINTI AND PARKER LIMITED (06568630), supporting that identity match without making Rianta the Tonic shareholder.^{36, 39}

The snapshot separately records AWESOMEACTION LIMITED at 17,292 A shares.³⁰ Companies House records Peter Noel Tighe as active director of AWESOMEACTION LIMITED (11166287) and former Tonic director; the root-supplied April 2026 resolution shows him signing for AwesomeAction, which is not treated as proof of beneficial ownership/control.^{40, 41} Fresh 6 October 2026 searches across these newly screened actors produced no opened public document establishing an attributable Israeli defence/security holding, board role, supply relationship or physical military-security output.^{32, 34, 36, 40} This is a bounded researched absence; private contracts, nominee positions, undisclosed holdings and unnamed LP exposure remain unresolved.³⁶

Earlier named-investor screening - retained bounded findings

The secondary gritt.io Board Observer lead for SidebySide partner Ben Ashworth was screened for Israeli defence/security ownership, board roles and military-welfare support.^{42, 43} No public evidence was identified in the opened bounded source set; private, nominee or undisclosed fund exposure cannot be excluded.

For Wray, Brendon Street lists him as a director, but its PSC is Juno Investments Ltd; Juno’s filing history records Wray ceasing to be its PSC on 29 October 2024 and Royal Bank of Canada becoming PSC that day.^{44, 45, 46} Maccabi GB says Wray started its 10km Community Fun Run in 2022 and lent an Olympic torch to the Maccabiah delegation. Israel Bonds/World Zionist Organisation separately sponsored the Fun Zone, while Beit Halochem and JNF UK were participating charities.⁴⁷ The source does not say Wray donated to, financed or held a role in those bodies. Nigel Wray is not a directly named holder in the dated register and beneficial/governance attribution through related vehicles remains unresolved; this is a potential-actor fact only and is not attributed to Tonic.

No opened document from the bounded Tom Singh/Rianta or Rubix screening established Israeli defence/security ownership, board roles or military-welfare donations. Rianta’s unnamed LP positions mean indirect exposure cannot be excluded.⁴⁸